Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: A systematic review
Man Li
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorHao Zheng
Department of Ultrasonography, Hebei Chest Hospital, Shijiazhuang, Hebei Province, China
Search for more papers by this authorTao Li
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorPing Gao
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorXiao-Lin Zhang
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorCorresponding Author
Dian-Wu Liu
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Professor Dian-Wu Liu., Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China. Email: [email protected]Search for more papers by this authorMan Li
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorHao Zheng
Department of Ultrasonography, Hebei Chest Hospital, Shijiazhuang, Hebei Province, China
Search for more papers by this authorTao Li
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorPing Gao
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorXiao-Lin Zhang
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Search for more papers by this authorCorresponding Author
Dian-Wu Liu
Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei Province, China
Professor Dian-Wu Liu., Department of Epidemiology, School of Public Health, Hebei Medical University, Shijiazhuang, 050017, Hebei Province, China. Email: [email protected]Search for more papers by this authorGrant support: This work was supported by grants from the National Natural Science Foundation of China (No: 30972516), Hebei Province National Natural Science Fund of China (No: C2010000481) and Hebei Health Department Fund of China (No: 20090004).
Abstract
Background and Aim: The cytotoxic T-lymphocyte antigen 4 (CTLA4) is an inhibitory receptor expressed on activated and regulatory T lymphocytes. Polymorphisms could have remarkable effects on susceptibility to autoimmunity. However, the associations between CTLA-4 polymorphisms and primary biliary cirrhosis (PBC) remain ambiguous. The aim of this meta-analysis is to determine more precise estimations of the relationship.
Methods: From literature retrieval from PubMed, Web of Science, Science Direct, and the Chinese National Knowledge Infrastructure (CNKI) Database, the publications on the associations between rs231775, rs3087243, rs5742909, rs231725 and rs11571317 polymorphisms of CTLA4 and PBC through June 2011 were collected. Odds ratios (OR) with 95% confidence intervals (95% CI) were calculated in fixed or random model, I2 was calculated to examine heterogeneity, and funnel plots were plotted to examine small study effects with Revman 5.1 and Stata 11.
Results: Overall, a significantly increased risk was found for G versus A allele for rs231775 (OR = 1.28, 95% CI = 1.17–1.41). For rs3087243, a significant association was found for AA versus GG genotype (OR = 0.66; 95% CI = 0.55–0.80). When subgroup analysis by ethnicity was performed, the same association was only found in Caucasians. For rs231725, the OR values (95% CI) for GG versus AA, GA versus AA and G versus A allele were 0.52 (0.40–0.68), 0.74 (0.60–0.92) and 0.73 (0.61–0.88). No significant associations were found for other polymorphisms.
Conclusion: The G allele of rs231775 is a risk factor for PBC, while AA genotype of rs3087243 and GG, GA and G allele of rs231725 show negative associations with PBC.
Supporting Information
Figure S1 Begg's funnel plots for the associations of rs231775 polymorphism and primary biliary cirrhosis.
Figure S2 Begg's funnel plots for the associations of rs5742909 polymorphism and primary biliary cirrhosis.
Figure S3 Begg's funnel plots for the associations of rs3087243 polymorphism and primary biliary cirrhosis.
| Filename | Description |
|---|---|
| JGH_7118_sm_FS1.tif401.5 KB | Supporting info item |
| JGH_7118_sm_FS2.tif471.4 KB | Supporting info item |
| JGH_7118_sm_FS3.tif413 KB | Supporting info item |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003; 362: 53–61.
- 2 Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008; 47: 737–45.
- 3 Jones DE. Pathogenesis of primary biliary cirrhosis. J. Hepatol. 2003; 39: 639–48.
- 4 Colucci G, Schaffner F, Paronetto F. In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin. Immunol. Immunopathol. 1986; 41: 35–42.
- 5 Migliaccio C, Van de Water J, Ansari AA et al. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology 2001; 33: 792–801.
- 6 Lan RY, Cheng C, Lian ZX et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006; 43: 729–37.
- 7 Chambers CA. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol. 2001; 22: 217–23.
- 8 Gough SC, Walker LS, Sansom DM. CTLA4 gene polymorphism and autoimmunity. Immunol. Rev. 2005; 204: 102–15.
- 9 Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J. Biol. Chem. 2002; 277: 46478–86.
- 10 Agarwal K, Jones DE, Daly AK et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 2000; 32: 538–41.
- 11 Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001; 2: 145–52.
- 12 Wang XB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein. Genes Immun. 2002; 3: 233–4.
- 13 Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506–11.
- 14 Huang Q, Shao F, Wang C, Qiu LJ, Hu YG, Yu JH. Association between CTLA-4 Exon-1 +49A>G Polymorphism and primary biliary cirrhosis risk: a meta-analysis. Arch. Med. Res. 2011; 42: 235–8.
- 15 Miyake Y, Ikeda F, Takaki A, Nouso K, Yamamoto K. +49A/G polymorphism of cytotoxic T-lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: a meta-analysis. Hepatol. Res. 2011; 41: 151–9.
- 16 Aiba Y, Nakamura M, Joshita S et al. Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. J. Gastroenterol. 2011; 46: 1203–12.
- 17 Bittencourt PL, Palacios SA, Farias AQ et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 2003; 18: 1061–6.
- 18 Donaldson P, Veeramani S, Baragiotta A et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 2007; 5: 755–60.
- 19 Fan LY, Tu XQ, Cheng QB et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J. Gastroenterol. 2004; 10: 3056–9.
- 20 Joshita S, Umemura T, Yoshizawa K et al. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J. Hepatol. 2010; 53: 537–41.
- 21 Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 2008; 47: 563–70.
- 22 Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary biliary cirrhosis is associated with a genetic variant in the 3′ flanking region of the CTLA4 gene. Gastroenterology 2008; 135: 1200–6.
- 23 Poupon R, Ping C, Chretien Y et al. Genetic factors of susceptibility and of severity in primary biliary cirrhosis. J. Hepatol. 2008; 49: 1038–45.
- 24 Schott E, Witt H, Pascu M et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur. J. Gastroenterol. Hepatol. 2007; 19: 947–51.
- 25 Walker EJ, Hirschfield GM, Xu C et al. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum. 2009; 60: 931–7.
- 26 Kanno Y, Rai T, Monoe K et al. Possible association of cytotoxic T lymphocyte antigen-4 genetic polymorphism with liver damage of primary biliary cirrhosis in Japan. Fukushima J. Med. Sci. 2006; 52: 79–85.
- 27 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.
- 28 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–101.
- 29 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–34.
- 30 Selmi C, Mayo MJ, Bach N et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485–92.
- 31 Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin. Liver Dis. 2005; 25: 265–80.
- 32 Garte S, Gaspari L, Alexandrie AK et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001; 10: 1239–48.
- 33 Ioannidis JP, Ntzani EE, Trikalinos TA. “Racial” differences in genetic effects for complex diseases. Nat. Genet. 2004; 36: 1312–18.
- 34 Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 1995; 181: 1835–45.
- 35 Miyakawa H, Tanaka A, Kikuchi K et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243–8.
- 36 Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J. Immunol. 1987; 138: 3525–31.
- 37 Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 2009; 50: 291–308.
- 38 Sakauchi F, Oura A, Ohnishi H, Mori M. Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid. J. Epidemiol. 2007; 17: 210–14.
Citing Literature
